Despite an increasing trend toward the utilization of catheter-directed therapies for PE, these therapies are not approved for MPE, and their primary prescription remains in the subset of patients with intermediate high-risk, intermediate low-risk, and SMPE.
← all excerpts
From Trendelenburg to PERTs: Evolution in the Management of Massive Pulmonary Embolism.
1
—
—